share_log

Chardan Capital Maintains Buy on Cargo Therapeutics, Maintains $28 Price Target

Chardan Capital Maintains Buy on Cargo Therapeutics, Maintains $28 Price Target

查丹資本維持對Cargo Therapeutics的買入評級,維持28美元的目標價
Benzinga ·  11/14 06:11  · 評級/大行評級

Chardan Capital analyst Geulah Livshits maintains Cargo Therapeutics (NASDAQ:CRGX) with a Buy and maintains $28 price target.

Chardan Capital分析師Geulah Livshits維持Cargo Therapeutics(納斯達克股票代碼:CRGX)的買入並維持28美元的目標股價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論